LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
54 hedge funds and large institutions have $70.9M invested in La Jolla Pharmaceutical Company in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
59% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 22
Holders
54
Holding in Top 10
2
Calls
$158K
Puts
$114K
Top Buyers
| 1 | +$1.08M | |
| 2 | +$190K | |
| 3 | +$183K | |
| 4 |
BlackRock
New York
|
+$162K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$108K |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$612K | |
| 3 | -$408K | |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$311K |
| 5 |
ERSOT
Employees Retirement System of Texas
Austin,
Texas
|
-$242K |